ALLMedicine™ Lower Gastrointestinal Bleeding Center
Research & Reviews 247 results
https://doi.org/10.1186/s12876-021-02037-4 10.1038/ajg.2016.41 10.1056/NEJMcp1603455 10.1038/ajg.2009.164 10.3748/wjg.v18.i11.1154 10.1016/j.gie.2011.06.024 10.1038/ajg.2009.687 10.1016/S0140-6736(00)02816-6 10.1111/j.1365-2036.2005.02485.x 10.1136/gutjnl-2019-320002 10.1001/archinte.163.7.838 10.1016/S1542-3565(04)00167-3 10.1111/j.1463-1318.2011.02824.x 10.1097/00003246-199707000-00011 10.1111/j.1572-0241.2005.41755.x 10.1016/j.amjmed.2016.12.009 10.1371/journal.pone.0196514 10.1016/S2468-1253(17)30150-4 10.1111/j.1572-0241.2001.03871.x 10.1097/00000658-198611000-00004
BMC Gastroenterology; Lee HS, Moon HS et. al.
Dec 1st, 2021 - Lower gastrointestinal bleeding (LGIB) often subsides without medical intervention; however, in some cases, the bleeding does not stop and the patient's condition worsens. Therefore, predicting severe LGIB in advance can aid treatment. This study ...
https://doi.org/10.1186/s12957-021-02443-8 10.1200/JCO.2007.14.9898 10.1016/S1470-2045(20)30527-1 10.1056/NEJMoa043116 10.1016/j.ctrv.2016.08.001 10.4253/wjge.v11.i5.383 10.5144/0256-4947.2012.661 10.1155/2012/154981 10.1136/bcr-2014-203647 10.3892/mco.2015.635 10.1159/000492781 10.7150/jca.37777 10.2169/internalmedicine.3340-19 10.1093/jjco/27.2.111 10.3748/wjg.v23.i1.42 10.1016/j.mayocp.2012.10.007 10.1093/annonc/mdl337 10.1157/13066853 10.1007/s11239-010-0525-x 10.1111/j.1572-0241.2004.30192.x 10.3233/TRD-170016 10.1111/j.1398-9995.2004.00547.x 10.1016/S0140-6736(16)32126-2 10.1016/j.disamonth.2017.07.001 10.4143/crt.2014.052 10.3816/CCC.2006.n.047 10.1200/JCO.2006.10.4182 10.1038/sj.tpj.6500476 10.3816/CCC.2010.n.033 10.1159/000510258 10.3332/ecancer.2020.1014 10.1093/annonc/mdx122 10.1016/S1470-2045(12)70345-5 10.1056/NEJMoa1414325 10.3892/ol.2015.3742 10.1002/cncr.23013
World Journal of Surgical Oncology; Zou Y, Liu S et. al.
Nov 24th, 2021 - Capecitabine is a prodrug that is enzymatically converted to its active form, fluorouracil (also called 5-fluorouracil), which is commonly used as adjuvant chemotherapy in colorectal cancer patients. Severe gastrointestinal bleeding induced by cap...
World Journal of Emergency Surgery : WJES; Singh M, Chiang J et. al.
Nov 24th, 2021 - Lower gastrointestinal bleeding (LGIB) is a common presentation of surgical admissions, imposing a significant burden on healthcare costs and resources. There is a paucity of standardised clinical predictive tools available for the initial assessm...
Journal of Vascular and Interventional Radiology : JVIR; Seyferth E, Dai R et. al.
Nov 20th, 2021 - To assess ischemic adverse events following particle embolization when used as a second-line embolic to coil embolization for treatment of acute lower gastrointestinal bleeding(LGIB). This single-institution retrospective study examined 154 proced...
Annals of the Royal College of Surgeons of England; Snelling S, Ghaffar R et. al.
Nov 4th, 2021 - The clinical presentation of lower gastrointestinal bleeding (LGIB) is variable in severity, cause and potential investigations. The British Society of Gastroenterology recently published LGIB guidelines, recommending CT angiography (CT-A) for hae...
Guidelines 2 results
Gut Oakland K, Chadwick G et. al.
Feb 23rd, 2019 - This is the first UK national guideline to concentrate on acute lower gastrointestinal bleeding (LGIB) and has been commissioned by the Clinical Services and Standards Committee of the British Society of Gastroenterology (BSG). The Guidelines Deve...
Endoscopy Tringali A, Thomson M et. al.
Sep 13th, 2016 - This Executive summary of the Guideline on pediatric gastrointestinal endoscopy from the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) refers to in...
Clinicaltrials.gov 5 results
Feb 3rd, 2021 - Inflammatory Bowel Disease (IBD), including crohn's disease and ulcerative colitis, is a group of diseases characterized by acute and chronic inflammation of the intestinal tract. Persons with IBD are at an increased risk of developing colorectal ...
Aug 28th, 2020 - This study is a randomized double-blind controlled trial study. Interventions were given in the form of tranexamic acid injection compared to placebo in patients with acute upper and lower gastrointestinal bleeding. Tranexamic acid were administer...
Aug 13th, 2020 - 1.0 BACKGROUND AND HYPOTHESES The investigators aim to prophylactically clip all colonic diverticula in patients who have experienced at least 1 episode of diverticular bleeding requiring hospitalization, but without definitive procedure (i.e., to...
Jan 20th, 2017 - This study is to evaluate the performance of Hemospray for the teatment of nonvariceal lower gastrointestinal bleeding.
Jul 7th, 2015 - Acute upper gastrointestinal bleeding is a common medical emergency. Up to 15% of patients still die worldwide. The gastroduodenal ulcer disease is the most common cause of gastrointestinal bleeding. Even lower gastrointestinal bleeding occurs esp...
News 16 results
Oct 6th, 2021 - Mark Burkard, MD, PhD Associate Professor, Medicine Mark Burkard, MD, PhD UW Carbone Cancer Center University of Wisconsin School of Medicine and Public Health Two years ago, I met a woman who had been living with breast cancer for nearl...
Mar 30th, 2021 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. The American College of Gastroenterology (ACG) just released the...
Jan 16th, 2020 - Gastroenterology November 2019 Clip closure after resection of large colorectal lesions with substantial risk of bleeding. Albéniz E et al.
Mar 22nd, 2019 - Clinical practice recommendations on the diagnosis and management of acute lower gastrointestinal bleeding (LGIB) were published in February 2019 by the British Society of Gastroenterology. Patients can be discharged for urgent outpatient inves...
Sharon Worcester, MDedge News
Oct 18th, 2017 - ORLANDO – TC-325 (Hemospray), a proprietary mineral powder blend developed for endoscopic hemostasis, promoted immediate hemostasis and prevented rebleeding in patients with malignant gastrointestinal bleeding in a randomized pilot trial. Nine of.